CureSeq advocates rapid solutions identifying cancer and other disease-causing mutations from patient biopsy samples. Applications include: 15 minute gDNA extraction from FFPE tissues for use in NGS, qPCR, Sanger Sequencing; NGS for targeted sequencing of driver mutations; fast and accurate targeted NGS data analysis. We now also offer clinical trial services.
| Website | http://www.cureseq.com |
| Revenue | $5.4 million |
| Employees | View employees |
| Founded | 2014 |
| Address | 150 N Hill Dr Ste 14, Brisbane, California 94005, US |
| Phone | +1 415-859-5468 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+10 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Bioinformatics, Business Services, Data and Analytics, Science and Engineering, Genetics, Health Care |
| Competitors | Roche, Guardant Health, GRAIL, Myriad Genetics, Foundation Medicine, Caris Life Sciences, Invitae, bluebird bio, Fulgent Genetics, 23andMe +41 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular CureSeq Inc. employee's phone or email?
CureSeq Inc. Questions
The CureSeq Inc. annual revenue was $5.4 million in 2026.
CureSeq Inc. is based in Brisbane, California.
The NAICS codes for CureSeq Inc. are [541, 541714, 5417, 54, 54171].
The SIC codes for CureSeq Inc. are [87, 873].
Related Companies
